-
High Levels of Activity, Motor Ability Linked to Better Cognition
drugs
January 17, 2019
In older adults, higher levels of total daily activity and better motor abilities are associated with better cognition, according to a study published online Jan. 16 in Neurology.....
-
Obesity Linked to Lower Gray Matter Brain Volume
drugs
January 10, 2019
Obesity is associated with lower gray matter brain volumes, according to a study published online Jan. 9 in Neurology.Mark Hammer, Ph.D., from Loughborough University, and G. David Batty, D.Sc., from .....
-
Pharma R&D productivity hits new low amid rising costs
pharmaphorum
December 20, 2018
Returns on pharma R&D investment are at a nine-year low, and the cost of developing a drug has nearly doubled since 2010, according to Deloitte’s yearly assessment of the industry’s pipeline productivity.
-
Minnetronix rebrands from contract manufacturer to in-house medtech developer
fiercebiotech
September 11, 2018
The renamed Minnetronix Medical has completed a first-in-human study for its Neurapheresis therapy and plans to begin an extended study this fall.
-
Merck's MS treatment shows promise in new data
pharmatimes
July 12, 2018
New data published in The Multiple Sclerosis Journal has shown more promising results for Merck's MS treatment Mavenclad (cladribine tablets) on two subgroups of patients with highly active relapsing multiple sclerosis.